0,893  0,001  Pneumotoxic
0,838  0,004  GST A substrate
0,788  0,004  Carcinogenic, group 3
0,786  0,005  Sensitization
0,770  0,004  NOS3 expression inhibitor
0,770  0,006  CYP1A2 substrate
0,769  0,009  CYP2C9 substrate
0,751  0,004  Genotoxic
0,732  0,003  Glutathione S-transferase substrate
0,721  0,005  UGT1A6 substrate
0,712  0,006  5 Hydroxytryptamine release stimulant
0,715  0,028  Apoptosis agonist
0,686  0,002  GST P1-1 substrate
0,702  0,024  Caspase 9 stimulant
0,678  0,003  Carcinogenic, group 2B
0,682  0,012  Carcinogenic
0,663  0,003  Porphobilinogen synthase inhibitor
0,649  0,005  UDP-glucuronosyltransferase substrate
0,648  0,010  CTGF expression inhibitor
0,642  0,010  CYP2D6 substrate
0,637  0,006  Antimutagenic
0,638  0,007  Skin irritative effect
0,634  0,005  GABA C receptor rho-3 antagonist
0,642  0,013  Chemoprotective
0,636  0,008  Eye irritation, high
0,623  0,003  Estrogen antagonist
0,614  0,003  Estrogen receptor beta antagonist
0,606  0,002  Phenylalanine 4-hydroxylase inhibitor
0,607  0,006  UGT1A4 substrate
0,613  0,017  Aldehyde oxidase inhibitor
0,606  0,013  Mutagenic
0,601  0,008  Free radical scavenger
0,600  0,011  Antioxidant
0,595  0,007  UGT1A1 substrate
0,612  0,028  CYP3A4 substrate
0,591  0,007  Superoxide dismutase inhibitor
0,606  0,024  TNF expression inhibitor
0,598  0,024  Teratogen
0,605  0,031  Transcription factor NF kappa B inhibitor
0,573  0,008  FMO1 substrate
0,572  0,013  AR expression inhibitor
0,581  0,024  Embryotoxic
0,567  0,041  Antineoplastic (breast cancer)
0,540  0,015  NOS2 expression inhibitor
0,531  0,007  Peroxidase inhibitor
0,530  0,007  UGT2B4 substrate
0,513  0,003  SULT1A3 substrate
0,508  0,006  Phospholipase C inhibitor
0,504  0,007  Skin whitener
0,513  0,018  Cardiovascular analeptic
0,499  0,006  Growth hormone agonist
0,491  0,003  Estrogen receptor beta agonist
0,495  0,008  Radiosensitizer
0,512  0,026  CYP2C19 substrate
0,507  0,021  Antineoplastic (cervical cancer)
0,482  0,013  Antihypertriglyceridemic
0,500  0,033  Cholesterol antagonist
0,469  0,006  FMO3 substrate
0,466  0,004  Estrogen agonist
0,478  0,021  Chemopreventive
0,494  0,041  Antileukemic
0,486  0,034  Histamine release inhibitor
0,477  0,027  Antineoplastic (melanoma)
0,458  0,009  Monophenol monooxygenase inhibitor
0,469  0,024  UGT1A9 substrate
0,448  0,007  5 Hydroxytryptamine uptake stimulant
0,450  0,011  Calcium channel activator
0,468  0,033  Respiratory analeptic
0,468  0,035  Vasodilator, peripheral
0,465  0,034  Bone diseases treatment
0,433  0,003  Ferrochelatase inhibitor
0,430  0,004  Carcinogenic, group 1
0,432  0,012  Flavin-containing monooxygenase substrate
0,463  0,044  Antipruritic, allergic
0,456  0,037  CYP2C19 inhibitor
0,425  0,012  Abortion inducer
0,421  0,009  GST M1-1 substrate
0,419  0,007  UGT2B15 substrate
0,460  0,053  Antibacterial
0,495  0,090  Antiinflammatory
0,406  0,008  Tyrosine 3 hydroxylase inhibitor
0,421  0,023  Nitric oxide antagonist
0,435  0,043  Ulceration
0,423  0,033  Antineoplastic (pancreatic cancer)
0,413  0,024  Cardiodepressant
0,434  0,045  Prostate cancer treatment
0,405  0,021  Sigma receptor agonist
0,411  0,028  Antiprotozoal (Leishmania)
0,391  0,008  Sulfotransferase substrate
0,390  0,009  NOS3 expression enhancer
0,420  0,040  Antihypercholesterolemic
0,414  0,034  Apoptosis antagonist
0,386  0,008  Interleukin 6 antagonist
0,391  0,014  Antiseptic
0,390  0,013  Melanin inhibitor
0,401  0,024  Amyloid beta aggregation inhibitor
0,432  0,058  Antineoplastic (lung cancer)
0,410  0,037  Radioprotector
0,397  0,025  Antihypoxic
0,408  0,038  Antineoplastic (brain cancer)
0,374  0,005  Succinate dehydrogenase inhibitor
0,402  0,032  Antineoplastic (non-small cell lung cancer)
0,404  0,036  Antiosteoporotic
0,404  0,044  Antifungal
0,387  0,030  Antipyretic
0,370  0,014  UGT1A3 substrate
0,387  0,031  DNA damaging
0,421  0,066  5 Hydroxytryptamine release inhibitor
0,368  0,013  VCAM1 expression inhibitor
0,393  0,039  Analeptic
0,394  0,041  12-Lipoxygenase inhibitor
0,390  0,038  Antineoplastic (glioma)
0,394  0,042  ICAM1 expression inhibitor
0,358  0,011  Alpha-N-acetylglucosaminidase inhibitor
0,383  0,038  Cytotoxic
0,348  0,005  Antispirochetal
0,387  0,047  Antineoplastic (ovarian cancer)
0,387  0,048  Caspase 3 stimulant
0,380  0,043  Cardioprotectant
0,405  0,072  15-Lipoxygenase inhibitor
0,350  0,018  Antihypotensive
0,365  0,036  Proliferative diseases treatment
0,335  0,007  Cystathionine beta-synthase inhibitor
0,338  0,011  Amyloid beta precursor protein antagonist
0,393  0,071  Antiprotozoal
0,331  0,012  Antihelmintic (Nematodes)
0,400  0,081  Calcium channel L-type activator
0,331  0,020  Contraceptive
0,369  0,060  Antineoplastic (colorectal cancer)
0,346  0,037  Antineoplastic (glioblastoma multiforme)
0,312  0,005  SULT1A1 substrate
0,323  0,016  Amylase inhibitor
0,343  0,036  Antineoplastic (endocrine cancer)
0,341  0,038  Transcription factor STAT inhibitor
0,313  0,010  Aldehyde dehydrogenase inhibitor
0,330  0,027  Anesthetic general
0,333  0,030  Antineoplastic enhancer
0,319  0,019  Antipruritic, non-allergic
0,315  0,017  Lipid peroxidase inhibitor
0,352  0,054  Vasodilator, coronary
0,301  0,005  Estrogen receptor alpha antagonist
0,347  0,052  Lipoxygenase inhibitor
0,310  0,016  CYP2B6 inhibitor
0,333  0,041  Insulysin inhibitor
0,340  0,048  Hypoxia-inducible factor 1 alpha inhibitor
0,294  0,003  Biliverdin reductase inhibitor
0,302  0,012  NADPH oxidase inhibitor
0,332  0,042  Hypoglycemic
0,312  0,024  UGT2B7 substrate
0,328  0,041  Transcription factor STAT3 inhibitor
0,314  0,029  ErbB-1 antagonist
0,322  0,042  Antineoplastic (liver cancer)
0,330  0,050  Antineoplastic (osteosarcoma)
0,289  0,012  Aldehyde oxidase substrate
0,303  0,027  5 Hydroxytryptamine 1E antagonist
0,280  0,005  Photosensitizer
0,282  0,007  Catenin beta inhibitor
0,317  0,044  Interleukin antagonist
0,288  0,016  Cyclooxygenase 1 inhibitor
0,315  0,043  Vasodilator
0,311  0,040  Antiparasitic
0,273  0,004  Estrogen receptor alpha agonist
0,286  0,016  MAO A inhibitor
0,344  0,075  Antiprotozoal (Plasmodium)
0,273  0,005  Alcohol oxidase inhibitor
0,281  0,013  UGT2B9 substrate
0,312  0,045  Pyruvate kinase inhibitor
0,288  0,022  Interferon gamma antagonist
0,298  0,032  Antihelmintic
0,281  0,016  Adenylate cyclase inhibitor
0,272  0,008  UGT2B10 substrate
0,266  0,004  Adenylate cyclase stimulant
0,349  0,087  Immunosuppressant
0,272  0,010  Age-related macular degeneration treatment
0,327  0,067  Antineoplastic (colon cancer)
0,269  0,012  GABA C receptor agonist
0,259  0,005  Creatine kinase inhibitor
0,262  0,009  GABA C receptor rho-2 antagonist
0,276  0,023  MAO inhibitor
0,257  0,005  Postmenopausal disorders treatment
0,262  0,014  5-Lipoxygenase inhibitor
0,268  0,021  CNS active muscle relaxant
0,248  0,003  SULT1A2 substrate
0,280  0,035  Hepatoprotectant
0,250  0,006  CF transmembrane conductance regulator agonist
0,259  0,016  Antifungal enhancer
0,270  0,027  Acaricide
0,248  0,007  Triose-phosphate isomerase inhibitor
0,267  0,028  Antiviral (Hepatitis)
0,248  0,010  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,261  0,024  Protein kinase stimulant
0,273  0,036  Peptidyltransferase inhibitor
0,260  0,024  Tubulin antagonist
0,261  0,026  Nitric-oxide synthase stimulant
0,254  0,022  Antiviral (Hepatitis C)
0,311  0,081  Antithrombotic
0,358  0,133  Antineoplastic (solid tumors)
0,231  0,007  TRPA1 agonist
0,229  0,004  SULT1E1 substrate
0,276  0,052  Cyclic AMP phosphodiesterase inhibitor
0,231  0,007  Antihelmintic (Fasciola)
0,236  0,012  Toll-Like receptor 2 antagonist
0,251  0,029  Hair growth stimulant
0,275  0,053  DNA synthesis inhibitor
0,263  0,041  Antiviral (Influenza)
0,262  0,042  DNA methyltransferase I inhibitor
0,255  0,035  Neurotrophic factor enhancer
0,238  0,019  Uterine stimulant
0,231  0,014  Antirickettsial
0,237  0,019  Antianemic
0,222  0,005  Glutamate decarboxylase inhibitor
0,247  0,031  Antiacne
0,255  0,039  Dual specificity phosphatase 3 inhibitor
0,235  0,019  Cell wall synthesis inhibitor
0,239  0,023  Neurotensin receptor agonist
0,256  0,041  Muscle relaxant
0,227  0,012  Cyclooxygenase 3 inhibitor
0,224  0,009  GABA C receptor antagonist
0,221  0,007  Keratolytic
0,221  0,008  Antiviral (Influenza B)
0,269  0,062  Angiogenesis stimulant
0,272  0,066  Antineoplastic (renal cancer)
0,219  0,013  Carbonic anhydrase III inhibitor
0,276  0,070  CYP1A2 inhibitor
0,213  0,008  Carcinogenic, group 2A
0,224  0,020  Chelator
0,217  0,013  UGT2B1 substrate
0,227  0,025  Antidiarrheal
0,206  0,005  Antidote, mercury
0,216  0,016  UDP-glucose 4-epimerase inhibitor
0,250  0,050  Sedative
0,220  0,022  Cholesterol synthesis inhibitor
0,248  0,051  RNA-directed DNA polymerase inhibitor
0,230  0,035  Heat shock protein 90 alpha antagonist
0,212  0,017  Carbonic anhydrase XV inhibitor
0,222  0,027  M18 aspartyl aminopeptidase inhibitor
0,196  0,001  Estrogen-related receptor beta antagonist
0,347  0,154  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,279  0,085  Immunostimulant
0,214  0,021  Arachidonic acid antagonist
0,257  0,064  Cytostatic
0,197  0,004  UGT2B11 substrate
0,262  0,070  Interleukin agonist
0,222  0,031  Antidote
0,197  0,007  Heat shock protein 70 antagonist
0,243  0,052  DNA methylase inhibitor
0,200  0,010  Papain-like protease (SARS coronavirus) inhibitor
0,216  0,026  Cocaine dependence treatment
0,201  0,012  Gastritis treatment
0,237  0,048  Non-steroidal antiinflammatory agent
0,193  0,004  GABA aminotransferase inhibitor
0,205  0,019  Microtubule formation inhibitor
0,219  0,033  VEGF expression inhibitor
0,199  0,013  Histidine decarboxylase inhibitor
0,229  0,043  Mcl-1 antagonist
0,190  0,005  Thioredoxin reductase inhibitor
0,192  0,008  DOPA decarboxylase inhibitor
0,201  0,019  Antiprotozoal (Amoeba)
0,195  0,013  Arylamine N-Acetyltransferase substrate
0,196  0,015  Adenylate kinase inhibitor
0,190  0,010  GABA C receptor rho-1 antagonist
0,232  0,051  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,189  0,010  Protein kinase C delta inhibitor
0,241  0,063  Antiulcerative
0,191  0,014  Vanilloid 1 agonist
0,217  0,041  LDLR expression enhancer
0,233  0,057  Antiviral (West Nile virus)
0,196  0,020  Xanthine oxidase inhibitor
0,187  0,011  Prolactin inhibitor
0,216  0,041  Protein-tyrosine phosphatase inhibitor
0,212  0,038  Antiviral (Influenza A)
0,215  0,041  Antiviral (Herpes)
0,225  0,051  Insulin sensitizer
0,219  0,047  Dual specificity phosphatase inhibitor
0,250  0,078  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,220  0,048  Sepsis treatment
0,181  0,009  Toll-Like receptor 4 antagonist
0,179  0,009  Beta tubulin antagonist
0,257  0,088  Spasmolytic
0,191  0,024  Antifungal (Cryptococcus)
0,180  0,013  Phosphofructokinase-1 inhibitor
0,191  0,025  Interleukin 4 antagonist
0,185  0,020  Alcohol dehydrogenase substrate
0,289  0,125  CYP2C9 inhibitor
0,175  0,011  HIV-1 integrase (3'-Processing) inhibitor
0,202  0,040  Skeletal muscle relaxant
0,179  0,017  HIV-1 integrase (Overall Integration) inhibitor
0,199  0,038  ATPase inhibitor
0,184  0,024  Excitatory amino acid transporter EAAC1 inhibitor
0,175  0,016  Carbonic anhydrase VI inhibitor
0,171  0,012  Ca2+-transporting ATPase inhibitor
0,170  0,011  HIV-1 integrase (Strand Transfer) inhibitor
0,235  0,076  Antiglaucomic
0,175  0,017  Androgen antagonist
0,168  0,010  Anabolic
0,175  0,019  Aldehyde dehydrogenase substrate
0,207  0,051  5 Hydroxytryptamine 3E antagonist
0,201  0,045  Prostate disorders treatment
0,225  0,071  Antiviral (HIV)
0,180  0,028  MAO B inhibitor
0,185  0,033  Protein-tyrosine phosphatase 1B inhibitor
0,251  0,103  Streptokinase A inhibitor
0,200  0,053  Tumour necrosis factor antagonist
0,162  0,015  NADH dehydrogenase inhibitor
0,169  0,024  Antiprotozoal (Babesia)
0,164  0,020  Beta glucuronidase inhibitor
0,154  0,010  Ornithine decarboxylase inhibitor
0,166  0,025  NAT2 substrate
0,160  0,020  Carbonic anhydrase XIII inhibitor
0,144  0,004  Estrogen-related receptor alpha antagonist
0,213  0,073  Psychostimulant
0,187  0,047  Cyclooxygenase inhibitor
0,171  0,032  Antibacterial (Helicobacter pylori)
0,187  0,049  Phobic disorders treatment
0,154  0,017  NAD(P)H dehydrogenase (quinone) inhibitor
0,163  0,027  Choleretic
0,153  0,018  Antifungal (Pneumocystis)
0,152  0,016  GST T1-1 substrate
0,181  0,047  Anesthetic
0,171  0,037  Alkylator
0,148  0,016  Macrophage migration inhibitory factor inhibitor
0,160  0,027  Contraceptive female
0,148  0,016  Glutamate dehydrogenase inhibitor
0,210  0,079  Antiparkinsonian, rigidity relieving
0,159  0,028  Mucolytic
0,138  0,008  Narcotic antagonist
0,160  0,030  Shock treatment
0,251  0,122  Angiogenesis inhibitor
0,160  0,032  Expectorant
0,178  0,050  Heat shock protein 90 antagonist
0,163  0,037  Antihelmintic (Trematoda)
0,132  0,006  Estrogen-related receptor beta agonist
0,129  0,004  Glucose-6-phosphate translocase inhibitor
0,145  0,021  Electrolyte absorption antagonist
0,129  0,005  Potassium channel Kv1.3 blocker
0,137  0,014  Phosphodiesterase 6D inhibitor
0,131  0,009  Androgen agonist
0,125  0,003  Adenylate cyclase 1 inhibitor
0,128  0,007  Endocannabinoid uptake inhibitor
0,138  0,017  Lanosterol 14 alpha demethylase inhibitor
0,134  0,013  Vanilloid agonist
0,140  0,020  ABCA1 expression enhancer
0,129  0,010  Purinergic P2X1 antagonist
0,135  0,016  Glutathione S-transferase inhibitor
0,129  0,010  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,285  0,167  Alpha-glucosidase inhibitor
0,138  0,021  Thioredoxin inhibitor
0,120  0,004  Factor III inhibitor
0,213  0,097  Neuropeptide Y2 antagonist
0,166  0,050  Alkaline phosphatase inhibitor
0,120  0,004  SULT2A1 substrate
0,119  0,005  MAP kinase kinase 7 inhibitor
0,117  0,003  Dopamine beta hydroxylase inhibitor
0,117  0,004  Postcoital contraceptive
0,124  0,012  D-Ala-D-Ala ligase inhibitor
0,170  0,058  Hexokinase inhibitor
0,144  0,032  Antineoplastic, alkylator
0,172  0,061  Cytidine deaminase inhibitor
0,186  0,075  P-glycoprotein inhibitor
0,154  0,043  Antihemorrhagic
0,196  0,086  Antimitotic
0,129  0,019  Antifungal (Aspergillus)
0,125  0,017  Aromatase inhibitor
0,149  0,041  Interleukin 1b antagonist
0,116  0,008  Antimycoplasmal
0,155  0,050  Antieczematic
0,146  0,043  Coagulant
0,152  0,049  Pregnane X receptor agonist
0,163  0,061  Antineoplastic (carcinoma)
0,159  0,057  Mannose-6-phosphate isomerase inhibitor
0,158  0,056  Movement disorders treatment
0,133  0,031  Breast cancer-resistant protein inhibitor
0,119  0,017  Sphingosine 1-phosphate receptor 4 agonist
0,106  0,004  Dopamine D5 agonist
0,106  0,005  Squalene epoxidase inhibitor
0,148  0,048  Cathepsin H inhibitor
0,150  0,050  Antiprotozoal (Trichomonas)
0,125  0,025  Opioid delta receptor antagonist
0,159  0,060  Antineoplastic (squamous cell carcinoma)
0,118  0,019  Nicotinic alpha4beta2 receptor antagonist
0,127  0,028  Topoisomerase II alpha inhibitor
0,108  0,009  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,112  0,014  Carbonic anhydrase VB inhibitor
0,157  0,060  Antiprotozoal (Coccidial)
0,127  0,030  Alcohol dehydrogenase inhibitor
0,147  0,051  Antihyperlipoproteinemic
0,203  0,107  Tumour necrosis factor alpha release inhibitor
0,108  0,013  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,114  0,018  HIV-1 integrase inhibitor
0,140  0,045  Antineoplastic (uterine cancer)
0,106  0,011  Antidote, organophosphates
0,117  0,022  Antiprotozoal activity enhancer
0,133  0,038  Mediator release inhibitor
0,134  0,039  Transcription factor STAT6 inhibitor
0,116  0,022  Carbonic anhydrase V inhibitor
0,110  0,016  Glycine receptor agonist
0,107  0,015  CC chemokine 5 receptor agonist
0,107  0,015  Acyl-CoA dehydrogenase inhibitor
0,098  0,006  Anesthetic inhalation
0,206  0,115  Antiprotozoal (Trypanosoma)
0,138  0,046  Sphingosine 1-phosphate receptor 4 antagonist
0,112  0,021  Dopamine D1 antagonist
0,102  0,011  Antiviral (Parainfluenza)
0,120  0,030  Paget's disease treatment
0,111  0,022  Na+ K+ transporting ATPase inhibitor
0,111  0,023  Granulocyte macrophage colony stimulating factor agonist
0,102  0,014  Phospholipase D inhibitor
0,109  0,021  Carbonic anhydrase VA inhibitor
0,133  0,045  Aminopeptidase B inhibitor
0,137  0,049  Antineoplastic antimetabolite
0,093  0,006  Dihydroorotate oxidase inhibitor
0,125  0,037  Antineoplastic antibiotic
0,169  0,081  Antineoplastic (gastric cancer)
0,187  0,100  Antialcoholic
0,119  0,032  Actinic keratosis treatment
0,097  0,011  Estradiol 17 beta-dehydrogenase inhibitor
0,207  0,121  Antituberculosic
0,232  0,148  Sodium/bile acid cotransporter inhibitor
0,093  0,008  Kainate receptor antagonist
0,089  0,006  Retinoid X receptor agonist
0,093  0,009  Heme oxygenase stimulant
0,087  0,005  Nicotinic acid receptor agonist
0,181  0,098  Histone acetyltransferase inhibitor
0,175  0,094  I kappa B kinase epsilon inhibitor
0,094  0,012  Exportin-1 inhibitor
0,091  0,010  Transcription factor RelA inhibitor
0,243  0,164  Antineoplastic (non-Hodgkin's lymphoma)
0,140  0,062  Cyclooxygenase 2 inhibitor
0,127  0,050  Caspase 3 inhibitor
0,104  0,026  NAT1 substrate
0,095  0,017  Xanthine dehydrogenase inhibitor
0,210  0,134  Gastrin inhibitor
0,106  0,030  Contraceptive male
0,081  0,005  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,107  0,031  Inducible nitric-oxide synthase inhibitor
0,096  0,020  Prostaglandin EP2 antagonist
0,091  0,015  Opioid mu receptor agonist
0,132  0,057  Proteasome inhibitor
0,079  0,004  Sodium-dependent vitamin C transporter 2 inhibitor
0,121  0,046  Acetylcholine release stimulant
0,147  0,072  Thiol protease inhibitor
0,108  0,034  Bile acid receptor antagonist
0,078  0,004  Kainate receptor agonist
0,113  0,039  Opioid antagonist
0,126  0,052  Topoisomerase I inhibitor
0,136  0,063  Sphingosine 1-phosphate receptor 2 antagonist
0,094  0,022  GABA B receptor agonist
0,112  0,040  NMDA receptor antagonist
0,108  0,036  Catalase inhibitor
0,091  0,021  S-adenosyl-L-methionine decarboxylase inhibitor
0,117  0,047  Anticataract
0,083  0,013  NMDA receptor subunit 3B antagonist
0,082  0,013  Aconitate hydratase inhibitor
0,092  0,023  Carbamoyl phosphate synthetase inhibitor
0,124  0,056  Interleukin 8 antagonist
0,084  0,016  MDM2 inhibitor
0,117  0,049  Antiprotozoal (Toxoplasma)
0,101  0,034  Myeloperoxidase inhibitor
0,097  0,030  Aminopeptidase I inhibitor
0,106  0,040  Antithrombocytopenic
0,252  0,185  Transcription factor inhibitor
0,136  0,071  Bone formation stimulant
0,114  0,049  Chronic obstructive bronchitis treatment
0,078  0,013  Lysine-specific demethylase 1A inhibitor
0,145  0,080  Raynaud's phenomenon treatment
0,117  0,052  Multidrug resistance-associated protein 1 inhibitor
0,141  0,078  Sphingosine 1-phosphate receptor 5 antagonist
0,097  0,035  Glycine receptor antagonist
0,147  0,085  Hearing loss treatment
0,075  0,013  Ryanodine receptor antagonist
0,088  0,026  Anticholelithogenic
0,066  0,005  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,114  0,054  Antiviral (Poxvirus)
0,096  0,036  Antibiotic
0,104  0,044  Antiviral (Rhinovirus)
0,134  0,074  Nav1.6 sodium channel blocker
0,104  0,044  Antifungal (Candida)
0,079  0,020  Alpha tubulin antagonist
0,097  0,038  Opioid kappa receptor antagonist
0,101  0,041  Glutamate release inhibitor
0,114  0,055  HDL-cholesterol increasing
0,176  0,117  Antineoplastic (lymphoma)
0,154  0,095  3C-like protease (Human coronavirus) inhibitor
0,079  0,021  Andropause treatment
0,070  0,012  Glucose-6-phosphate isomerase inhibitor
0,109  0,052  Dementia treatment
0,067  0,010  Kainate receptor 2 antagonist
0,081  0,024  Antidote, heavy metal
0,075  0,018  Cyclin B2 inhibitor
0,080  0,024  Glutamate (mGluR6) antagonist
0,086  0,030  Antitreponemal
0,090  0,035  Histone deacetylase SIRT1 stimulant
0,090  0,035  Histone deacetylase stimulant
0,081  0,026  Glutamate (mGluR7) antagonist
0,091  0,035  Opioid mu receptor antagonist
0,113  0,059  Protein kinase C gamma inhibitor
0,106  0,051  Vascular dementia treatment
0,060  0,006  Heme oxygenase inhibitor
0,101  0,047  Potassium channel activator
0,114  0,061  5 Hydroxytryptamine 3A agonist
0,069  0,015  Leukotriene C antagonist
0,124  0,070  MAP kinase kinase inhibitor
0,067  0,014  Fructose-1,6-bisphosphatase inhibitor
0,073  0,020  Sphingosine kinase 2 inhibitor
0,063  0,010  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,119  0,067  Anesthetic local
0,062  0,010  Inosine monophosphate dehydrogenase inhibitor
0,104  0,052  Potassium channel (Ca-activated) activator
0,109  0,057  Urease inhibitor
0,120  0,069  Growth stimulant
0,056  0,005  Sodium/glucose cotransporter 2 inhibitor
0,091  0,041  CYP2A6 inhibitor
0,076  0,026  Alpha 2 adrenoreceptor agonist
0,067  0,017  Antiviral (Herpesvirus 3, Human)
0,060  0,011  Retinoid X alpha receptor agonist
0,093  0,044  Acetylcholine nicotinic antagonist
0,136  0,089  Acetylcholine M1 receptor antagonist
0,066  0,019  Pregnane X receptor antagonist
0,076  0,028  TRPA1 antagonist
0,115  0,068  Menstruation disorders treatment
0,052  0,005  HCV polyprotein inhibitor
0,085  0,038  CDC25A inhibitor
0,111  0,065  Endometrios treatment
0,086  0,040  NMDA 2 receptor antagonist
0,136  0,091  Phospholipase A2 inhibitor
0,061  0,016  NMDA receptor subunit 3A antagonist
0,183  0,138  Lipoprotein disorders treatment
0,106  0,061  Alpha 2c adrenoreceptor antagonist
0,197  0,153  Antimycobacterial
0,074  0,029  Beta 3 adrenoreceptor antagonist
0,166  0,122  Hypolipemic
0,115  0,071  Topoisomerase II inhibitor
0,074  0,032  Aryl hydrocarbon receptor antagonist
0,053  0,012  Opioid delta receptor agonist
0,063  0,021  Prolyl endopeptidase inhibitor
0,057  0,016  Progesterone antagonist
0,045  0,004  Nicotinic acid receptor 2 antagonist
0,056  0,015  Liver X receptor alpha agonist
0,088  0,048  Adrenaline agonist
0,055  0,016  Guanylate cyclase inhibitor
0,078  0,038  Vanilloid 1 antagonist
0,069  0,030  Argininosuccinate synthase inhibitor
0,077  0,039  Neuronal nicotinic receptor antagonist
0,060  0,021  HCV NS3/NS4A protease inhibitor
0,071  0,032  NMDA 2C receptor antagonist
0,090  0,051  Transcription factor NF kappa B stimulant
0,050  0,012  Retinoid X receptor antagonist
0,047  0,009  ATP citrate lysase inhibitor
0,052  0,014  GABA uptake inhibitor
0,047  0,010  Catechol O-methyltransferase inhibitor
0,060  0,023  Heparanase inhibitor
0,163  0,126  Aryl hydrocarbon receptor agonist
0,041  0,005  Estrogen-related receptor gamma antagonist
0,064  0,027  Cyclin B inhibitor
0,080  0,044  Metalloproteinase-9 inhibitor
0,062  0,026  Leukotriene B4 antagonist
0,047  0,011  Vanilloid 3 antagonist
0,049  0,013  Glutamate (mGluR8) agonist
0,062  0,026  Epithelial sodium channel blocker
0,042  0,006  Sodium/glucose cotransporter inhibitor
0,122  0,086  Interleukin 1 antagonist
0,073  0,038  Leukotriene antagonist
0,041  0,007  CYP24 inhibitor
0,069  0,036  Neuraminidase (influenza) inhibitor
0,057  0,023  Potassium channel (Inward rectifier) activator
0,125  0,092  Farnesoid X receptor antagonist
0,050  0,017  Dihydropteroate synthase inhibitor
0,057  0,024  CD45 antagonist
0,038  0,005  Vanilloid 2 agonist
0,066  0,033  Dopamine uptake inhibitor
0,062  0,030  Ornithine carbamoyltransferase inhibitor
0,038  0,006  Prostaglandin F2 alpha agonist
0,078  0,045  Vanilloid 4 agonist
0,046  0,014  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,058  0,026  Carbonic anhydrase XIV inhibitor
0,166  0,135  Antiviral (Ebola)
0,054  0,023  Potassium channel (ATP-sensitive) activator
0,105  0,074  Antiviral (Coronavirus)
0,105  0,074  Antiviral (SARS coronavirus)
0,109  0,078  DNA polymerase I inhibitor
0,162  0,131  Antiamyloidogenic
0,122  0,091  Antiparkinsonian, tremor relieving
0,063  0,032  Fatty acid synthase inhibitor
0,042  0,011  Uridine phosphorylase inhibitor
0,064  0,033  Sphingosine kinase inhibitor
0,037  0,006  Sodium/glucose cotransporter 1 inhibitor
0,035  0,005  Complement factor 1s inhibitor
0,045  0,015  Leukotriene C4 antagonist
0,034  0,004  Vesicular glutamate transport inhibitor
0,037  0,007  Thyroid hormone agonist
0,063  0,033  Botulinum neurotoxin type A inhibitor
0,045  0,015  CF transmembrane conductance regulator antagonist
0,068  0,038  5 Hydroxytryptamine 2A agonist
0,052  0,022  Oxytocin agonist
0,073  0,043  Elastase 1 inhibitor
0,068  0,039  Protease 3C (Human rhinovirus) inhibitor
0,053  0,024  Thymidylate synthase inhibitor
0,097  0,069  Nav1.1 sodium channel blocker
0,067  0,039  NMDA receptor glycine site agonist
0,041  0,014  Retinoid X alpha receptor antagonist
0,032  0,005  ICAM 1 antagonist
0,091  0,064  Protein kinase C zeta inhibitor
0,065  0,038  Neuraminidase inhibitor
0,060  0,034  Maillard reaction inhibitor
0,058  0,032  Opioid agonist
0,100  0,074  Alpha 2b adrenoreceptor antagonist
0,039  0,014  Prostaglandin agonist
0,132  0,107  MAP kinase kinase 4 inhibitor
0,055  0,029  Lysophosphatidic acid 3 receptor antagonist
0,067  0,041  CDC25B inhibitor
0,051  0,026  Carbonic anhydrase VII inhibitor
0,030  0,005  Neuraminidase (Influenza B) inhibitor
0,029  0,004  Antibiotic Anthracycline-like
0,042  0,017  Squalene synthetase inhibitor
0,031  0,007  Fructose-1,6-bisphosphatase 1 inhibitor
0,056  0,032  Alpha-mannosidase inhibitor
0,037  0,013  Glutamate (mGluR3) agonist
0,031  0,007  Inosine monophosphate dehydrogenase 2 inhibitor
0,076  0,052  Alpha 2a adrenoreceptor antagonist
0,043  0,020  Cholesterol absorption inhibitor
0,069  0,046  Protein kinase C alpha inhibitor
0,044  0,021  5-Alpha-reductase inhibitor
0,065  0,043  Hyperparathyroidism treatment
0,062  0,040  Beta 2 adrenoreceptor agonist
0,093  0,072  Nitric-oxide synthase inhibitor
0,032  0,011  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,066  0,045  Selectin antagonist
0,067  0,046  Potassium channel (ATP-sensitive) blocker
0,063  0,043  NMDA receptor agonist
0,026  0,006  Retinoid X beta receptor antagonist
0,066  0,045  Beta adrenoreceptor antagonist
0,030  0,010  Kainate receptor 1 antagonist
0,219  0,199  Antineoplastic (small cell lung cancer)
0,036  0,016  AMPA 3 receptor antagonist
0,083  0,063  Histamine N-methyltransferase inhibitor
0,052  0,033  Beta 2 adrenoreceptor antagonist
0,033  0,014  Nicotinic alpha4beta2 receptor agonist
0,041  0,022  Vesicle monoamine transporter inhibitor
0,056  0,037  Glucosylceramidase inhibitor
0,042  0,023  AMPA 4 receptor antagonist
0,196  0,177  CYP3A4 inhibitor
0,038  0,020  Fumarate hydratase inhibitor
0,053  0,035  NMDA 2A receptor antagonist
0,037  0,020  RNA-directed RNA polymerase inhibitor
0,035  0,018  AMPA 1 receptor antagonist
0,041  0,024  Retinoic acid alpha receptor agonist
0,041  0,025  Membrane dipeptidase inhibitor
0,113  0,097  Toll-Like receptor antagonist
0,114  0,099  Antianorexic
0,027  0,012  Prostaglandin E2 agonist
0,053  0,038  Nicotinic receptor alpha7 subunit antagonist
0,025  0,011  Monocarboxylic acid transporter 1 inhibitor
0,025  0,011  Monocarboxylic acid transporter inhibitor
0,072  0,058  Phosphodiesterase VI inhibitor
0,040  0,026  Alpha 1d adrenoreceptor agonist
0,088  0,074  Sphingomyelinase inhibitor
0,021  0,008  Nicotinic acid receptor 1 antagonist
0,167  0,153  Calpain inhibitor
0,080  0,066  Alpha 2 adrenoreceptor antagonist
0,022  0,008  Estrogen-related receptor gamma agonist
0,045  0,032  Mannosidase inhibitor
0,061  0,048  5 Hydroxytryptamine 3 agonist
0,054  0,042  Beta 1 adrenoreceptor antagonist
0,032  0,021  HCV NS5B polymerase inhibitor
0,026  0,014  Glutamate (mGluR1) agonist
0,024  0,012  Retinoic acid gamma receptor agonist
0,067  0,057  Calcium channel L-type blocker
0,082  0,072  Tocolytic
0,039  0,029  VCAM-1 antagonist
0,037  0,027  Diamine oxidase inhibitor
0,221  0,211  DNA directed DNA polymerase inhibitor
0,021  0,012  Antibiotic Quinolone-like
0,039  0,029  VCAM antagonist
0,047  0,038  Topoisomerase II beta inhibitor
0,053  0,044  Immunoglobulin Fc receptor antagonist
0,018  0,009  Prostaglandin EP4 agonist
0,064  0,055  Gaucher disease treatment
0,042  0,034  Geranyltranstransferase inhibitor
0,142  0,134  Toxic, respiratory center
0,108  0,100  DNA repair enzyme inhibitor
0,086  0,079  Bronchodilator
0,027  0,020  NMDA 2D receptor antagonist
0,120  0,113  Antidiabetic (type 1)
0,017  0,012  Telomerase stimulant
0,031  0,025  GABA transporter 3 inhibitor
0,052  0,046  Glutamate (mGluR1) antagonist
0,019  0,014  Alpha 2b adrenoreceptor agonist
0,057  0,052  Enoyl-[acyl-carrier-protein] reductase inhibitor
0,070  0,066  Metalloproteinase-2 inhibitor
0,032  0,028  Tubulin agonist
0,027  0,022  Liver X receptor beta antagonist
0,042  0,038  Adenosine deaminase inhibitor
0,046  0,042  Dihydroorotate dehydrogenase inhibitor
0,042  0,039  Purinergic P2X4 antagonist
0,032  0,029  Phosphoglycerate kinase inhibitor
0,029  0,026  Nucleoside transporters inhibitor
0,177  0,175  Prostaglandin dehydrogenase inhibitor
0,009  0,006  Thyroid hormone beta agonist
0,043  0,041  Beta adrenoreceptor agonist
0,065  0,062  Vanilloid antagonist
0,215  0,213  DNA polymerase beta inhibitor
0,014  0,012  NMDA receptor phencyclidine site antagonist
0,021  0,019  Vitamin D receptor antagonist
0,025  0,024  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,035  0,034  Potassium channel Kv1.1 blocker
0,017  0,016  Methylmalonyl-CoA mutase inhibitor
0,168  0,168  Antineurogenic pain
0,077  0,077  mTOR complex 2 inhibitor

